Imcyse SA
Dissolution volontaire – liquidation 41.9 FTEImcyse reported revenue of €1.53m for the 2024 financial year (annual accounts filed with the NBB on 13 Aug 2024), with 41.9 full-time equivalents.
The score of Imcyse shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Revenue +237 % Total assets -87 % Headcount (avg FTE) +16 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Imcyse's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue | €1.53m | ||||
| Net result | −€6.24m | ||||
| Equity | −€33.4m | ||||
| Cash | €2.82m | ||||
| EBITDA | −127,816 € | ||||
| Total assets | €4.80m |
Filed annual accounts
- Year ended 21 May 2024filed on 13 Aug 2024
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 06 Jul 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
- Year ended 31 Dec 2020filed on 08 Jul 2021
Imcyse's financial analysis
- Solvency-695.2%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Imcyse
Imcyse's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0828.385.542
- VAT number
- BE0828385542
- Peppol
- Registered · 0208:0828385542 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 10 Aug 2010
- Registered office
- 4031 Liège
- Size
- Small · 41.9 FTE
- Latest accounts
- 2024 · filed on 13 Aug 2024
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Imcyse (SA) has been based in Liège since 2010, active in: research and experimental development on biotechnology. For 2024, it reports revenue of €1.53m, a net loss of €6.24m and equity of −€33.4m. With 41.9 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at -695.2%, below the median of its sector (58.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Imcyse
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- Hebrimo Solar 21 Research and experimental development on natural sciences and engineering Herentals · balance sheet €4.71m
- CM4Cure Research and experimental development on natural sciences and engineering Liège · balance sheet €4.57m
- BioKuris Research and experimental development on natural sciences and engineering Herstal · balance sheet €5.85m
- HepaVue Dx Research and experimental development on natural sciences and engineering Waterloo · balance sheet €3.71m
- Envitec Measurements and Analytics SA Research and experimental development on natural sciences and engineering Gembloux · balance sheet €3.64m
- K5 Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €3.56m
- ImmuneSpec Research and experimental development on natural sciences and engineering Niel · balance sheet €3.54m
Frequently asked questions about Imcyse
What is the revenue of Imcyse?
According to the 2024 annual accounts filed with the NBB, the revenue of Imcyse amounts to 1,529,443 €.
What is the VAT number of Imcyse?
In Belgium, the VAT number is the company number prefixed with BE: BE0828385542 for Imcyse, if the company is VAT-registered. Its company number (CBE) is 0828.385.542.
Where is the registered office of Imcyse?
According to the CBE register, the registered office of Imcyse is in 4031 Liège.
What is the equity of Imcyse?
At the close of the 2024 financial year, the equity of Imcyse amounts to -33,378,817 €, a solvency of -695.2% of total assets.
How many people work at Imcyse?
41.9 full-time equivalents on average according to the 2024 social balance sheet.
Who manages Imcyse?
The register lists 14 active mandates at Imcyse. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Imcyse
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →